SLC2A1 and cancer: The objective of our analysis was to value the relationship of elevated GLUT1 expression status with prognostic outcomes in solid human tumors, and illustrate the clinical value of GLUT1 as a prognostic indicator and potential therapeutic target for malignant tumor patients.